KYTHERA Biopharmaceuticals to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
June 03, 2015 16:58 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., June 03, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that John Smither, chief financial officer, will present at the Goldman...
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
May 19, 2015 19:41 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., May 19, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on May 15, 2015, the Compensation Committee of the Company’s Board of...
KYTHERA Biopharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
May 08, 2015 18:31 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., May 8, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the...
KYTHERA Biopharmaceuticals Releases First Quarter 2015 Operating Results and Progress Update
May 07, 2015 16:05 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for the first quarter of 2015, and provided an update on...
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
May 06, 2015 18:05 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on May 1, 2015, the Compensation Committee of the Company’s Board of...
KYTHERA Biopharmaceuticals to Release First Quarter 2015 Operating Results
April 30, 2015 16:56 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its first quarter 2015 operating results and will host an...
Multimedia Release -- KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA(TM) (also known as ATX-101) -- First and Only Submental Contouring Injectable Drug
April 30, 2015 09:00 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH), issued a release on Wednesday, April 29, with the headline "Photo Release -- KYTHERA...
Photo Release -- KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA(TM) (also known as ATX-101) -- First and Only Submental Contouring Injectable Drug
April 29, 2015 15:58 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) announced today that the U.S. Food and Drug Administration (FDA) has approved...
KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
April 06, 2015 01:22 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., April 6, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on March 27, 2015, the Compensation Committee of the Company's Board of...
KYTHERA Biopharmaceuticals Announces 2015 Outlook Call
March 19, 2015 19:38 ET
|
KYTHERA Biopharmaceuticals, Inc.
WESTLAKE VILLAGE, Calif., March 19, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will host a 2015 Outlook investor call and webcast at 4:30 p.m. ET on...